AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 291: L175-L180, 2006. First published February 17, 2006; doi:10.1152/ajplung.00547.2005
1040-0605/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/2/L175    most recent
00547.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vermeer, P. D.
Right arrow Articles by Zabner, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vermeer, P. D.
Right arrow Articles by Zabner, J.

Differentiation of human airway epithelia is dependent on erbB2

Paola D. Vermeer,1 Lacey Panko,1 Philip Karp,1 John H. Lee,2 and Joseph Zabner1

1Department of Internal Medicine, University of Iowa Roy J. and Lucille A. Carver College of Medicine; and 2Department of Otolaryngology, Head and Neck Surgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa

Submitted 30 December 2005 ; accepted in final form 1 February 2006

A clinical case documented a reversible change in airway epithelial differentiation that coincided with the initiation and discontinuation of trastuzumab, an anti-erbB2 antibody. This prompted the investigation into whether blocking the erbB2 receptor alters differentiation of the airway epithelium. To test this hypothesis, we treated an in vitro model of well-differentiated human airway epithelia with trastuzumab or heregulin-{alpha}, an erbB ligand. In addition, coculturing with human lung fibroblasts tested whether in vivo subepithelial fibroblasts function as an endogenous source of ligands able to activate erbB receptors expressed by the overlying epithelial cells. Epithelia were stained with hematoxylin and eosin and used for morphometric analysis. Trastuzumab treatment decreased the ciliated cell number by 49% and increased the metaplastic, flat cell number by 640%. Heregulin-{alpha} treatment increased epithelial height and decreased the number of metaplastic and nonciliated columnar cells, whereas it increased the goblet cell number. We found that normal human lung fibroblasts express transforming growth factor-{alpha}, heparin-binding epidermal-like growth factor, epiregulin, heregulin-{alpha}, and amphiregulin, all of which are erbB ligands. Cocultures of airway epithelia with primary fibroblasts increased epithelial height comparable to that achieved following heregulin-{alpha} treatment. These data show that erbB2 stimulation is required for maintaining epithelial differentiation. Furthermore, the mesenchyme underlying the airway epithelium secretes a variety of erbB ligands that may direct various pathways of epithelial differentiation.

trastuzumab; fibroblasts



Address for reprint requests and other correspondence: J. Zabner, Univ. of Iowa Roy J. and Lucille A. Carver College of Medicine, 440 EMRB, Iowa City, IA 52242 (e-mail: joseph-zabner{at}uiowa.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. T. N. Trinh, A. Prive, L. Kheir, J.-C. Bourret, T. Hijazi, M. G. Amraei, J. Noel, and E. Brochiero
Involvement of KATP and KvLQT1 K+ channels in EGF-stimulated alveolar epithelial cell repair processes
Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L870 - L882.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. M. Myerburg, J. D. Latoche, E. E. McKenna, L. P. Stabile, J. S. Siegfried, C. A. Feghali-Bostwick, and J. M. Pilewski
Hepatocyte growth factor and other fibroblast secretions modulate the phenotype of human bronchial epithelial cells
Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1352 - L1360.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
P. LeSimple, I. van Seuningen, M.-P. Buisine, M.-C. Copin, M. Hinz, W. Hoffmann, R. Hajj, S. L. Brody, C. Coraux, and E. Puchelle
Trefoil Factor Family 3 Peptide Promotes Human Airway Epithelial Ciliated Cell Differentiation
Am. J. Respir. Cell Mol. Biol., March 1, 2007; 36(3): 296 - 303.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
E. Puchelle, J.-M. Zahm, J.-M. Tournier, and C. Coraux
Airway Epithelial Repair, Regeneration, and Remodeling after Injury in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, November 1, 2006; 3(8): 726 - 733.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.